Drug · DIN 02230785
TAZORAC
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since September 22, 2023; first marketed April 10, 1997.
- Drug Identification Number (DIN)
- 02230785
- Company (DIN owner)
- Allergan IncMarkham, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Gel
- Route
- Topical
- Therapeutic class (ATC)
- Tazarotene D05AX05
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TAZAROTENE | 0.1 % |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 25, 1997: NOC 4122New Drug Submission (NDS)
Other DINs named TAZORAC
- DIN 02230784 · Cancelled Post Market
- DIN 02243894 · Cancelled Post Market
- DIN 02243895 · Cancelled Post Market